Injection-site reactions (ISRs) are common adverse reactions to biological drugs, consisting of itching, erythema and induration at the injection site.1 ISRs usually appear within 24–48 h of injection and subside within a few days. They typically occur in the first 2 months of treatment and subsequently decrease in frequency; incidence varies by drug. While ISRs seldom result in discontinuation of treatment, they remain a safety concern when using biological drugs.
Titolo: | Comparison of injection-site reactions between the etanercept biosimilar SB4 and the reference etanercept in patients with rheumatoid arthritis from a phase III study. |
Autori: | |
Data di pubblicazione: | 2018 |
Rivista: | |
Abstract: | Injection-site reactions (ISRs) are common adverse reactions to biological drugs, consisting of itching, erythema and induration at the injection site.1 ISRs usually appear within 24–48 h of injection and subside within a few days. They typically occur in the first 2 months of treatment and subsequently decrease in frequency; incidence varies by drug. While ISRs seldom result in discontinuation of treatment, they remain a safety concern when using biological drugs. |
Handle: | http://hdl.handle.net/11562/977187 |
Appare nelle tipologie: | 01.01 Articolo in Rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Girolomoni G Comparison of injection-site reactions BJD 2018.pdf | Documento in Post-print | Accesso ristretto | Utenti riconosciuti Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.